Published in Behav Brain Res on February 17, 2011
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther (2011) 2.13
Targeting G protein coupled receptor-related pathways as emerging molecular therapies. Saudi Pharm J (2013) 1.06
The evolving impact of g protein-coupled receptor kinases in cardiac health and disease. Physiol Rev (2015) 0.97
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy. Neuropharmacology (2011) 0.88
Diffusion kurtosis imaging and high-resolution MRI demonstrate structural aberrations of caudate putamen and amygdala after chronic mild stress. PLoS One (2014) 0.87
Region-specific roles of the corticotropin-releasing factor-urocortin system in stress. Nat Rev Neurosci (2016) 0.85
Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness. Psychopharmacology (Berl) (2013) 0.83
Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Life Sci (2014) 0.77
G protein-coupled receptor kinase-2 (GRK-2) regulates serotonin metabolism through the monoamine oxidase AMX-2 in Caenorhabditis elegans. J Biol Chem (2017) 0.75
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev (2005) 4.64
Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry (2004) 4.32
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry (2002) 3.82
The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol (2005) 3.09
Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci (2007) 2.51
The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta (2006) 2.24
Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J Neurosci (2003) 1.91
Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology (2006) 1.81
Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry (2010) 1.60
Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci (2009) 1.59
Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res (1983) 1.54
Learned helplessness and animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry (1984) 1.47
Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther (1997) 1.34
Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats. Behav Brain Res (2010) 1.30
Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens. J Neurosci (2009) 1.30
Learned helplessness: validity and reliability of depressive-like states in mice. Brain Res Brain Res Protoc (2005) 1.29
Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci (2004) 1.26
Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci (1990) 1.18
Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment. J Neurochem (2007) 1.11
Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience (1999) 1.07
The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res (2009) 1.06
Depression in an animal model: focus on the locus ceruleus. Ciba Found Symp (1986) 1.05
Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides (2005) 1.04
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry (1999) 1.04
Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J Neurochem (1998) 1.03
Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res Mol Brain Res (2001) 1.02
Carbonylated proteins in aging and exercise: immunoblot approaches. Mech Ageing Dev (1999) 1.01
GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization. Biochem Biophys Res Commun (2002) 1.00
Effect of number of tailshocks on learned helplessness and activation of serotonergic and noradrenergic neurons in the rat. Behav Brain Res (2005) 0.95
Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization. Biochem Biophys Res Commun (2000) 0.91
GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation. Am J Physiol Regul Integr Comp Physiol (2001) 0.90
Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus. Neuropharmacology (1986) 0.90
Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. Neuromolecular Med (2005) 0.89
Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Brain Res Mol Brain Res (2003) 0.85
Further evidence for association of GRK3 to bipolar disorder suggests a second disease mutation. Psychiatr Genet (2007) 0.84
Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex. Biol Psychiatry (2006) 0.84
Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Psychopharmacology (Berl) (2009) 0.83
Role of 90-kDa heat shock protein (Hsp 90) and protein degradation in regulating neuronal levels of G protein-coupled receptor kinase 3. J Pharmacol Exp Ther (2006) 0.83
Prevention of learned helplessness: in vivo correlation with cortical serotonin. Pharmacol Biochem Behav (1992) 0.82
Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure. Neuropharmacology (2002) 0.82
Cellular G protein-coupled receptor kinase levels regulate sensitivity of the {alpha}2b-adrenergic receptor to undergo agonist-induced down-regulation. J Pharmacol Exp Ther (2004) 0.82
Activation of the CRF(1) receptor causes ERK1/2 mediated increase in GRK3 expression in CATH.a cells. FEBS Lett (2007) 0.82
The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment. BMC Pharmacol (2007) 0.80
Learned helplessness sensitizes hippocampal norepinephrine to mild restress. Biol Psychiatry (1994) 0.78
Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am J Med (2004) 2.18
The impact of apathy on glycemic control in diabetes: a cross-sectional study. Diabetes Res Clin Pract (2007) 1.53
Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behav Brain Res (2011) 1.39
Sexual assault in women veterans: an examination of PTSD risk, health care utilization, and cost of care. Psychosom Med (2004) 1.31
Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats. Behav Brain Res (2010) 1.30
Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol (2007) 1.27
Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res (2013) 1.23
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther (2007) 1.16
Somnambulism due to probable interaction of valproic acid and zolpidem. Ann Pharmacother (2003) 1.09
Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci (2004) 1.07
Aripiprazole possibly worsens psychosis. Int Clin Psychopharmacol (2004) 1.06
Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease. Neurobiol Aging (2009) 1.04
Inert medication ingredients causing nonadherence due to religious beliefs. Ann Pharmacother (2004) 1.00
Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats. J Nutr (2013) 1.00
Methylphenidate for apathy and functional status in dementia of the Alzheimer type. Am J Geriatr Psychiatry (2010) 0.95
Manic episode during treatment with aripiprazole. Am J Psychiatry (2007) 0.95
Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain. J Pharmacol Exp Ther (2005) 0.95
Grape powder intake prevents ovariectomy-induced anxiety-like behavior, memory impairment and high blood pressure in female Wistar rats. PLoS One (2013) 0.95
Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J Pharmacol Exp Ther (2007) 0.94
Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord (2005) 0.94
Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology (Berl) (2008) 0.93
Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice. Brain Res (2006) 0.93
Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War. Psychiatry Res (2009) 0.92
Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. J Neurosci Methods (2007) 0.91
Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology (2003) 0.90
Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. Eur J Pharmacol (2007) 0.89
Treatment of apathy with methylphenidate. J Neuropsychiatry Clin Neurosci (2007) 0.88
Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells. J Pharmacol Exp Ther (2007) 0.88
Differential expression of molecular markers of synaptic plasticity in the hippocampus, prefrontal cortex, and amygdala in response to spatial learning, predator exposure, and stress-induced amnesia. Hippocampus (2011) 0.88
Alternative translation initiation of human regulators of G-protein signaling-2 yields a set of functionally distinct proteins. Mol Pharmacol (2007) 0.88
Aripiprazole reduces alcohol use. Can J Psychiatry (2005) 0.87
Methylphenidate may treat apathy independent of depression. Ann Pharmacother (2005) 0.87
Pharmacologic principles for combination therapy. Proc Am Thorac Soc (2005) 0.87
Novel role of RGS2 in regulation of antioxidant homeostasis in neuronal cells. FEBS Lett (2011) 0.87
The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment. Neuropharmacology (2007) 0.86
Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Curr Alzheimer Res (2013) 0.85
Mirtazapine for Charles Bonnet syndrome. Can J Psychiatry (2004) 0.85
Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study. Neurochem Int (2009) 0.84
A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol (2004) 0.84
Patient and physician attitudes to using medications with religiously forbidden ingredients. Ann Pharmacother (2004) 0.84
Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol (2006) 0.84
Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.84
Simultaneous alpha2B- and beta2-adrenoceptor activation sensitizes the alpha2B-adrenoceptor for agonist-induced down-regulation. J Pharmacol Exp Ther (2004) 0.84
Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res (2008) 0.84
Effect of ischemia reperfusion on sodium-dependent phosphate transport in renal brush border membranes. Biochim Biophys Acta (2005) 0.83
Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Psychopharmacology (Berl) (2009) 0.83
Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats. Pharmacogenomics J (2005) 0.83
Down-regulation of the alpha-2C adrenergic receptor: involvement of a serine/threonine motif in the third cytoplasmic loop. BMC Pharmacol (2002) 0.83
Desensitization of alpha 2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by beta 2-adrenoceptor-dependent GRK3 up-regulation. Br J Pharmacol (2003) 0.83
Quetiapine therapy for posttraumatic stress disorder. Ann Pharmacother (2002) 0.83
Role of 90-kDa heat shock protein (Hsp 90) and protein degradation in regulating neuronal levels of G protein-coupled receptor kinase 3. J Pharmacol Exp Ther (2006) 0.83
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol (2008) 0.82
Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines. Bioorg Med Chem Lett (2005) 0.82
Acute psychosis with Coricidin cold medicine. Ann Pharmacother (2005) 0.82
Cellular G protein-coupled receptor kinase levels regulate sensitivity of the {alpha}2b-adrenergic receptor to undergo agonist-induced down-regulation. J Pharmacol Exp Ther (2004) 0.82
Activation of the CRF(1) receptor causes ERK1/2 mediated increase in GRK3 expression in CATH.a cells. FEBS Lett (2007) 0.82
Influence of Ramadan-type fasting on enzymes of carbohydrate metabolism and brush border membrane in small intestine and liver of rat used as a model. Br J Nutr (2006) 0.82
Potential use of olanzapine in treatment of substance dependence disorders. J Clin Psychopharmacol (2003) 0.81
Effect of ischemia and reperfusion on enzymes of carbohydrate metabolism in rat kidney. J Nephrol (2004) 0.80
Neurobiological consequences of sleep deprivation. Curr Neuropharmacol (2013) 0.80
Diagnosis and treatment of alcohol dependence in older alcoholics. Clin Geriatr Med (2003) 0.80
A high-salt diet further impairs age-associated declines in cognitive, behavioral, and cardiovascular functions in male Fischer brown Norway rats. J Nutr (2013) 0.80
Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther (2006) 0.80
Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study. S D Med (2007) 0.80
The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment. BMC Pharmacol (2007) 0.80
Adrenergic receptor genes: cDNA and genomic library construction. Mol Biotechnol (2002) 0.80
Valproate therapy for chronic, combat-induced posttraumatic stress disorder. J Clin Psychopharmacol (2002) 0.79
Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids. Ann Allergy Asthma Immunol (2009) 0.79
A transient expression of functional alpha2-adrenergic receptors in white matter of the developing brain. Synapse (2005) 0.78
Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptors. Am J Physiol Endocrinol Metab (2007) 0.78
A primary care perspective of posttraumatic stress disorder for the Department of Veterans Affairs. Prim Care Companion J Clin Psychiatry (2005) 0.77
Modafinil for remitted bipolar depression with hypersomnia. Ann Pharmacother (2003) 0.77
Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration. BMC Pharmacol (2008) 0.76
Clinical pearls to manage cyberchondriacs. Prim Care Companion J Clin Psychiatry (2008) 0.75
Propranolol treatment for neuroleptic-induced akathisia. Prim Care Companion J Clin Psychiatry (2005) 0.75
Ziprasidone therapy for post-traumatic stress disorder. J Psychiatry Neurosci (2005) 0.75
Are medical students assigning proper global assessment of functioning scores? Acad Psychiatry (2007) 0.75
Adjunctive aripiprazole in combat-related posttraumatic stress disorder. Ann Pharmacother (2007) 0.75
Addiction training scale: pilot study of a self-report evaluation tool for psychiatry residents. Acad Psychiatry (2004) 0.75
Duloxetine associated with smoking cessation. Ann Pharmacother (2005) 0.75
Sotalol-induced depression. Ann Pharmacother (2004) 0.75
Zolpidem-induced mania in a patient with schizoaffective disorder. Psychosomatics (2011) 0.75
Quetiapine therapy for corticosteroid-induced mania. Can J Psychiatry (2005) 0.75